Dashboard
Manage Tickers

GILDGILEAD SCIENCES, INC.

Nasdaq gilead.com


$ 65.44 $ 0.15 (0.23 %)    

Friday, 26-Apr-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 65.42
$ 65.09
$ 0.00 x 0
$ 0.00 x 0
$ 64.66 - $ 66.33
$ 64.63 - $ 86.97
12,382,425
na
82.3B
$ 0.35
$ 14.53
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-23-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-04-2023 06-30-2023 10-Q
4 05-03-2023 03-31-2023 10-Q
5 02-22-2023 12-31-2022 10-K
6 11-02-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-04-2022 03-31-2022 10-Q
9 02-23-2022 12-31-2021 10-K
10 11-03-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 02-25-2021 12-31-2020 10-K
14 11-04-2020 09-30-2020 10-Q
15 08-06-2020 06-30-2020 10-Q
16 05-06-2020 03-31-2020 10-Q
17 02-25-2020 12-31-2019 10-K
18 11-05-2019 09-30-2019 10-Q
19 08-06-2019 06-30-2019 10-Q
20 05-08-2019 03-31-2019 10-Q
21 02-26-2019 12-31-2018 10-K
22 11-06-2018 09-30-2018 10-Q
23 08-06-2018 06-30-2018 10-Q
24 05-09-2018 03-31-2018 10-Q
25 02-27-2018 12-31-2017 10-K
26 11-07-2017 09-30-2017 10-Q
27 08-07-2017 06-30-2017 10-Q
28 05-10-2017 03-31-2017 10-Q
29 02-27-2017 12-31-2016 10-K
30 11-07-2016 09-30-2016 10-Q
31 08-05-2016 06-30-2016 10-Q
32 05-06-2016 03-31-2016 10-Q
33 02-24-2016 12-31-2015 10-K
34 11-04-2015 09-30-2015 10-Q
35 08-05-2015 06-30-2015 10-Q
36 05-08-2015 03-31-2015 10-Q
37 02-25-2015 12-31-2014 10-K
38 11-05-2014 09-30-2014 10-Q
39 08-04-2014 06-30-2014 10-Q
40 05-07-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

gilead-sciences-unusual-options-activity
Gilead Sciences Unusual Options Activity
04/26/2024 19:15:47

td-cowen-maintains-buy-on-gilead-sciences-lowers-price-target-to-85
TD Cowen Maintains Buy on Gilead Sciences,...
04/26/2024 17:25:25

TD Cowen analyst Tyler Van Buren maintains Gilead Sciences (NASDAQ:GILD) with a Buy and lowers the price target from $90 to ...

morgan-stanley-maintains-equal-weight-on-gilead-sciences-lowers-price-target-to-78
Morgan Stanley Maintains Equal-Weight on G...
04/26/2024 16:42:39

Morgan Stanley analyst Matthew Harrison maintains Gilead Sciences (NASDAQ:GILD) with a Equal-Weight and lowers the price tar...

rbc-capital-maintains-sector-perform-on-gilead-sciences-lowers-price-target-to-74
RBC Capital Maintains Sector Perform on Gi...
04/26/2024 15:46:21

RBC Capital analyst Brian Abrahams maintains Gilead Sciences (NASDAQ:GILD) with a Sector Perform and lowers the price target...

fda-approves-biktarvy-label-update-with-data-for-pregnant-adults-with-hiv-perinatal-guidelines-recognize-biktarvy-as-alternative-regimen-for-use-during-pregnancy-and-for-those-trying-to-conceive
FDA Approves Biktarvy Label Update With Da...
04/26/2024 12:05:55

– Additional Data in Pregnant Adults Who Are Virologically Suppressed Reinforce Safety and Tolerability Profile of Biktarvy in ...

needham-reiterates-hold-on-gilead-sciences
Needham Reiterates Hold on Gilead Sciences
04/26/2024 10:21:04

Needham analyst Joseph Stringer reiterates Gilead Sciences (NASDAQ:GILD) with a Hold.

gilead-sees-fy24-adj-eps-345-385
Gilead Sees FY24 Adj. EPS $3.45-$3.85
04/25/2024 20:04:30

gilead-sciences-sees-fy24-sales-271b-275b-vs-27982b
Gilead Sciences Sees FY24 Sales $27.1B-$27...
04/25/2024 20:03:39

gilead-sciences-q1-2024-adj-eps-132-beats-149-estimate-sales-610b-miss-634b-estimate
Gilead Sciences Q1 2024 Adj EPS $(1.32) Be...
04/25/2024 20:02:59

Gilead Sciences (NASDAQ:GILD) reported quarterly losses of $(1.32) per share which beat the analyst consensus estimate of $(1.4...

stocks-drop-tech-tumbles-with-metas-weak-outlook-q1-stagflation-fears-gold-miners-advance-whats-driving-markets-thursday
Stocks Drop, Tech Tumbles With Meta's Weak...
04/25/2024 17:30:32

Wall Street suffers a double blow in Thursday’s session, as softer-than-expected revenue forecasts from Meta Platforms Inc. (NA...

wall-streets-most-accurate-analysts-views-on-3-health-care-stocks-delivering-high-dividend-yields
Wall Street's Most Accurate Analysts' View...
04/25/2024 11:54:20

us-stocks-brace-for-negative-start-amid-tech-earnings-disappointments-caution-ahead-of-data-worst-of-this-two-week-decline-is-behind-us-says-analyst
US Stocks Brace For Negative Start Amid Te...
04/25/2024 10:17:18

The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platfor...

hsbc-upgrades-gilead-sciences-to-hold-announces-69-price-target
HSBC Upgrades Gilead Sciences to Hold, Ann...
04/24/2024 17:54:38

HSBC analyst Morten Herholdt upgrades Gilead Sciences (NASDAQ:GILD) from Reduce to Hold and announces $69 price target.

why-is-penny-stock-hookipa-pharma-trading-higher-on-wednesday
Why Is Penny Stock HOOKIPA Pharma Trading ...
04/24/2024 14:31:37

HOOKIPA Pharma secures FDA clearance for its innovative HB-700 therapeutic vaccine targeting KRAS-mutated cancers. Learn about ...

can-magnificent-7-help-script-market-turnaround-earnings-pick-up-pace-with-microsoft-meta-alphabet-and-tesla-expected-this-week
Can Magnificent 7 Help Script Market Turna...
04/21/2024 21:45:15

Corporate profit growth rose in Q3 2023 and is expected to continue in Q1.

Core News & Articles
Leap Therapeutics 13G Filing Shows Gilead ...
04/19/2024 20:43:40

- SEC Filing

the-analyst-verdict-gilead-sciences-in-the-eyes-of-12-experts
The Analyst Verdict: Gilead Sciences In Th...
04/19/2024 19:00:37

oppenheimer-maintains-outperform-on-gilead-sciences-maintains-105-price-target
Oppenheimer Maintains Outperform on Gilead...
04/19/2024 14:57:31

Oppenheimer analyst Hartaj Singh maintains Gilead Sciences (NASDAQ:GILD) with a Outperform and maintains $105 price target.

fda-mandates-boxed-warning-for-bristol-myers-johnson--johnson-car-t-based-blood-cancer-therapies
FDA Mandates "Boxed Warning" For Bristol M...
04/19/2024 13:28:52

Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—t...

what-the-options-market-tells-us-about-gilead-sciences
What the Options Market Tells Us About Gil...
04/18/2024 17:16:14

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION